Domani Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $513K | Hold |
7,405
| – | – | 0.12% | 73 |
|
|
2022
Q4 | $533K | Buy |
7,405
+57
| +0.8% | +$4.3K | 0.13% | 70 |
|
|
2022
Q3 | $522K | Hold |
7,348
| – | – | 0.15% | 59 |
|
|
2022
Q2 | $566K | Hold |
7,348
| – | – | 0.15% | 60 |
|
|
2022
Q1 | $537K | Buy |
7,348
+83
| +1% | +$5.57K | 0.12% | 77 |
|
|
2021
Q4 | $453K | Hold |
7,265
| – | – | 0.09% | 81 |
|
|
2021
Q3 | $430K | Hold |
7,265
| – | – | 0.09% | 76 |
|
|
2021
Q2 | $485K | Sell |
7,265
-876
| -11% | -$57.1K | 0.1% | 73 |
|
|
2021
Q1 | $514K | Hold |
8,141
| – | – | 0.1% | 72 |
|
|
2020
Q4 | $505K | Sell |
8,141
-1,000
| -11% | -$61.5K | 0.1% | 67 |
|
|
2020
Q3 | $551K | Buy |
9,141
+1,000
| +12% | +$60.2K | 0.12% | 71 |
|
|
2020
Q2 | $479K | Hold |
8,141
| – | – | 0.11% | 73 |
|
|
2020
Q1 | $454K | Sell |
8,141
-324
| -4% | -$19.8K | 0.12% | 72 |
|
|
2019
Q4 | $543K | Hold |
8,465
| – | – | 0.18% | 61 |
|
|
2019
Q3 | $429K | Hold |
8,465
| – | – | 0.16% | 65 |
|
|
2019
Q2 | $384K | Hold |
8,465
| – | – | 0.14% | 69 |
|
|
2019
Q1 | $404K | Hold |
8,465
| – | – | 0.16% | 71 |
|
|
2018
Q4 | $440K | Hold |
8,465
| – | – | 0.2% | 57 |
|
|
2018
Q3 | $526K | Sell |
8,465
-2,000
| -19% | -$119K | 0.23% | 51 |
|
|
2018
Q2 | $579K | Hold |
10,465
| – | – | 0.27% | 49 |
|
|
2018
Q1 | $662K | Sell |
10,465
-75
| -0.7% | -$4.83K | 0.28% | 42 |
|
|
2017
Q4 | $646K | Hold |
10,540
| – | – | 0.28% | 46 |
|
|
2017
Q3 | $672K | Hold |
10,540
| – | – | 0.29% | 47 |
|
|
2017
Q2 | $587K | Sell |
10,540
-1,125
| -10% | -$61.2K | 0.24% | 55 |
|
|
2017
Q1 | $634K | Sell |
11,665
-1,006
| -8% | -$55.2K | 0.26% | 53 |
|
|
2016
Q4 | $740K | Buy |
12,671
+500
| +4% | +$27.3K | 0.3% | 49 |
|
|
2016
Q3 | $656K | Buy |
12,171
+1,500
| +14% | +$96.4K | 0.25% | 56 |
|
|
2016
Q2 | $785K | Sell |
10,671
-1,428
| -12% | -$101K | 0.3% | 52 |
|
|
2016
Q1 | $774K | Buy |
12,099
+1,428
| +13% | +$90.1K | 0.29% | 59 |
|
|
2015
Q4 | $734K | Sell |
10,671
-800
| -7% | -$52.9K | 0.29% | 55 |
|
|
2015
Q3 | $679K | Sell |
11,471
-1,100
| -9% | -$69.8K | 0.37% | 43 |
|
|
2015
Q2 | $836K | Buy |
12,571
+11,760
| +1,450% | +$775K | 0.46% | 37 |
|
|
2015
Q1 | $12.6K | Buy |
+811
| New | +$50.8K | 0.19% | 44 |
|
Other funds holding BMY
Domani Wealth's BMY Position: Q1 2023 in Review
Domani Wealth held its Bristol-Myers Squibb (BMY) position steady in Q1 2023 at 7,405 shares worth $513K. The position accounts for 0.12% of the portfolio, ranked #73.
Domani Wealth first reported a position in BMY in Q1 2015 and has held it in 33 quarters since. The position peaked at $836K in Q2 2015. 2,541 funds tracked by Wall St. Rank hold BMY as of Q1 2023.
- Domani Wealth held 7,405 shares of Bristol-Myers Squibb worth $513K as of Q1 2023.
- Domani Wealth left its Bristol-Myers Squibb share count unchanged in Q1 2023.
- Bristol-Myers Squibb made up 0.12% of Domani Wealth's portfolio in Q1 2023, its #73 holding.
- Domani Wealth first reported a position in Bristol-Myers Squibb in Q1 2015 and has held it in 33 quarters since.
- Domani Wealth's Bristol-Myers Squibb position peaked at $836K in Q2 2015.
- 2,541 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.
Based on Domani Wealth's 13F filing for Q1 2023, filed 19 Apr 2023.